Alignment Healthcare, Inc. $ALHC Shares Acquired by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC boosted its stake in Alignment Healthcare, Inc. (NASDAQ:ALHC) by 1.6% in the second quarter, Holdings Channel.com reports. The fund owned 652,152 shares of the company’s stock after buying an additional 9,989 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Alignment Healthcare were worth $9,267,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. increased its position in shares of Alignment Healthcare by 13.2% during the first quarter. Vanguard Group Inc. now owns 11,113,896 shares of the company’s stock worth $206,941,000 after purchasing an additional 1,295,825 shares in the last quarter. T. Rowe Price Investment Management Inc. grew its stake in Alignment Healthcare by 5.0% during the 1st quarter. T. Rowe Price Investment Management Inc. now owns 9,078,113 shares of the company’s stock worth $169,035,000 after buying an additional 429,071 shares during the last quarter. Wellington Management Group LLP increased its position in Alignment Healthcare by 0.9% during the first quarter. Wellington Management Group LLP now owns 7,509,057 shares of the company’s stock worth $139,819,000 after buying an additional 70,557 shares during the period. 8 Knots Management LLC lifted its stake in Alignment Healthcare by 28.9% in the first quarter. 8 Knots Management LLC now owns 4,715,472 shares of the company’s stock valued at $87,802,000 after buying an additional 1,056,777 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD lifted its stake in Alignment Healthcare by 9.7% in the first quarter. Price T Rowe Associates Inc. MD now owns 2,199,421 shares of the company’s stock valued at $40,954,000 after buying an additional 193,644 shares during the last quarter. Hedge funds and other institutional investors own 86.19% of the company’s stock.

Insider Buying and Selling at Alignment Healthcare

In other Alignment Healthcare news, insider Christopher J. Joyce sold 30,939 shares of Alignment Healthcare stock in a transaction dated Wednesday, September 10th. The shares were sold at an average price of $16.41, for a total transaction of $507,708.99. Following the completion of the transaction, the insider owned 343,592 shares in the company, valued at approximately $5,638,344.72. The trade was a 8.26% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO John E. Kao sold 355,018 shares of Alignment Healthcare stock in a transaction that occurred on Wednesday, September 10th. The stock was sold at an average price of $16.41, for a total value of $5,825,845.38. Following the transaction, the chief executive officer owned 4,533,568 shares of the company’s stock, valued at $74,395,850.88. This represents a 7.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 7,443,207 shares of company stock worth $119,848,080. Insiders own 7.00% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have recently issued reports on ALHC shares. KeyCorp upgraded shares of Alignment Healthcare from a “sector weight” rating to an “overweight” rating and set a $21.00 target price on the stock in a research report on Monday, August 25th. Zacks Research raised shares of Alignment Healthcare from a “hold” rating to a “strong-buy” rating in a research report on Monday, September 29th. Wall Street Zen cut shares of Alignment Healthcare from a “buy” rating to a “hold” rating in a report on Sunday, August 10th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Alignment Healthcare in a research note on Wednesday, October 8th. Finally, The Goldman Sachs Group started coverage on Alignment Healthcare in a research report on Tuesday. They issued a “buy” rating and a $21.00 price target on the stock. Two analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $19.05.

Alignment Healthcare Trading Up 0.8%

Shares of Alignment Healthcare stock opened at $17.12 on Friday. The company has a 50-day moving average of $16.40 and a two-hundred day moving average of $15.62. Alignment Healthcare, Inc. has a 12-month low of $10.11 and a 12-month high of $21.06. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 2.29. The stock has a market cap of $3.39 billion, a PE ratio of -61.14 and a beta of 1.18.

Alignment Healthcare (NASDAQ:ALHC) last issued its quarterly earnings data on Wednesday, July 30th. The company reported $0.07 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.07) by $0.14. The firm had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $960.25 million. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.Alignment Healthcare’s revenue was up 49.0% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.13) earnings per share. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. On average, research analysts anticipate that Alignment Healthcare, Inc. will post -0.69 EPS for the current fiscal year.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.